Additionally, BRAF V600E mutations are frequently observed in pleomorphic xanthoastrocytoma (about 80%), ganglioglioma (roughly 45%) and paediatric‐type diffuse low‐grade gliomas (approximately 40%) [44, 48, 49, 50, 51]. This evidence concerns the gene BRAF and ganglioglioma.